
Opinion: To learn lessons from pandemics, don’t listen to big pharma
Early in the Covid-19 pandemic, the leaders of wealthy countries pledged to respond with “global…

Early in the Covid-19 pandemic, the leaders of wealthy countries pledged to respond with “global…

The Food and Drug Administration announced Wednesday that it has authorized a booster shot for…

After an extraordinary three-day hearing, an expert panel of advisers to the U.S. Food and…

The phrase “Black Death mass burial site” tends to evoke images of haphazard piles of…

Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…

After years of deliberation, the FDA recently announced a new set of rules it proposes…

In the rapidly changing landscape of digital health, innovation has often outpaced regulations, especially for…

Since the world began confronting a global outbreak of monkeypox in the spring, the scientific…

When Sarka Lisonkova and her colleagues set out to study disparities in the birth outcomes…
.jpg)
The director of a Boston University laboratory that conducted potentially controversial research on the viruses…
.jpg)
WASHINGTON — The Biden administration is suing six vape shops after the companies ignored Food…

Amid ongoing controversy over the cost of insulin, a new analysis finds that approximately 1.3…

Top of the morning to you. Another busy day is unfolding on the Pharmalot satellite…

The Biden administration on Tuesday unveiled a new national biodefense strategy, aiming to adapt lessons…

WASHINGTON — Biden health officials are bracing for the prospect that the country’s sole preventive…

Expansions to social safety net programs during Covid-19 have been essential for low-income Americans hit…

A fourth-year medical student, Tema, faced an abrupt interruption to her education earlier this year….

Research at Boston University that involved testing a lab-made hybrid version of the SARS-CoV-2 virus…

The Department of Justice filed a new lawsuit against Cigna Monday, alleging the health insurance…

Drugmakers’ powerhouse lobby did not exactly make good on its early August threat to hold…

Good morning, everyone, and welcome to another working week. We hope the weekend respite was…

Josh Bilenker’s last company, Loxo Oncology, was purchased by Eli Lilly for $8 billion. No…

Milestone Pharmaceuticals said Monday that an experimental nasal-spray medicine acted quickly to treat people experiencing…

The next big Alzheimer’s disease study readout is almost here. Roche is nearing the completion…

The University of Pennsylvania’s Division of Renal-Electrolyte and Hypertension recently made a quiet update to…

Before the Covid-19 pandemic emerged, influenza trackers would begin reading tea leaves around this time…

In an unusual step, the European Public Prosecutor’s Office (EPPO) confirmed it has opened an…

When it comes to eradicating infectious diseases, there can be no half measures: it’s an…

Insurance giant UnitedHealth Group’s strong financial showing in the third quarter was driven in part…

A group of Republican senators is demanding to know what steps the U.S. National Institutes…

And so, another working week will soon draw to a close. Not a moment too…

Amid rising concern over antibiotic resistance, a new report finds that a dozen of the…

With health emergencies becoming more common, the world needs more efficient ways to test the…

Forty years ago, in his Pulitzer Prize-winning history “The Social Transformation of American Medicine,” sociologist…

On Sunday, the New England Journal of Medicine published the interim results of a landmark…

When Hurricane Fiona knocked out power across the entire island of Puerto Rico, hospitals turned…

In 2011, Walgreens executives were under pressure. Amid a growing addiction crisis, and with the…

What’s going on at biotech’s lobbying organization? Where does mRNA go from here? And what…

Research often proceeds in a logical progression, new studies building upon a detailed understanding of…

South Korea’s anti-trust regulator has fined AstraZeneca and a local generic drugmaker a total of…

Hello, everyone, and how are you today? Cloudy skies are hovering this morning over the…

Relmada Therapeutics said Thursday that its experimental treatment for depression failed to achieve the primary…

In the numbers game of disease statistics, type 1 diabetes takes a back seat to…

BOSTON — BioNTech CEO Uğur Şahin had been in marathon meetings since he arrived in…

The biopharma industry is failing Americans, economically and medically. U.S. biotechnology and pharmaceutical companies, like…

Every two years since 1994, scientists have come together for an experiment — better described…

CARLSBAD, Calif. — Biotech companies developing cutting-edge cell and gene therapies often are tripped up…

Merck on Wednesday agreed to extend an ongoing collaboration with Moderna to develop a personalized…

The U.S. Food and Drug Administration and a trade group that represents large compound pharmacies…

The scientist flicked on a laser, filling the rat’s brain with blue light. The rodent,…